This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hojo, S Articles by Kinoshita, M Search for Related Content PubMed PubMed Citation Articles by Hojo, S Articles by Kinoshita, M

Original Articles

Heterogeneous point mutations of the p53 gene in pulmonary fibrosis

Lung cancer is a frequent complication in pulmonary fibrosis. Overexpression of p53 proteins has been demonstrated by immunostaining in bronchoepithelial cells in patients with idiopathic pulmonary fibrosis. However, it is still unclear whether this overexpressed p53 protein is wild-type or mutant. It was hypothesized that pulmonary fibrosis may be a precancerous lesion with deoxyribonucleic acid point mutations in bronchoepithelial cells. Mutations of the p53 gene were tested for by fluorescence-based single-strand conformation polymorphism (FSSCP), cloning-sequencing and immunostaining techniques. Out of 10 tissue samples that demonstrated overexpression of p53 protein by immunostaining, nine (90%) exhibited point mutations and eight (80%) exhibited heterogeneous point mutations of the p53 gene. The mutations found in pulmonary fibrosis were scattered throughout the central part of the p53 gene, and both guanine (G):cytosine (C) to adenine (A):thymine (T) and A:T to G:C transitions were frequently observed. In conclusion, frequent heterogeneous point mutations of the p53 gene were detected in pulmonary fibrosis. These mutations may have resulted from several types of deoxyribonucleic acid damage that occurred in bronchoepithelial cells and this may explain previous findings of a very high incidence of lung cancer complicating pulmonary fibrosis.

This article has been cited by other articles:

				C. Vancheri, M. Failla, N. Crimi, and G. Raghu Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Eur. Respir. J., March 1, 2010; 35(3): 496 - 504. [Abstract] [Full Text] [PDF]

				A. Watanabe, T. Higami, S. Ohori, T. Koyanagi, S. Nakashima, and T. Mawatari Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1357 - 1363.e2. [Abstract] [Full Text] [PDF]

				D. A. Schwartz Genetic Analysis of Sporadic and Familial Interstitial Pneumonia Proceedings of the ATS, April 15, 2008; 5(3): 343 - 347. [Abstract] [Full Text] [PDF]

				Y. Terasaki, T. Akuta, M. Terasaki, T. Sawa, T. Mori, T. Okamoto, M. Ozaki, M. Takeya, and T. Akaike Guanine Nitration in Idiopathic Pulmonary Fibrosis and Its Implication for Carcinogenesis Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 665 - 673. [Abstract] [Full Text] [PDF]

				J. C. Grutters and R. M. du Bois Genetics of fibrosing lung diseases Eur. Respir. J., May 1, 2005; 25(5): 915 - 927. [Abstract] [Full Text] [PDF]

				P. Hainaut and G. P. Pfeifer Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis, March 1, 2001; 22(3): 367 - 374. [Abstract] [Full Text] [PDF]